Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma.
- Published in:
- Gene Therapy, 2006, v. 13, n. 17, p. 1263, doi. 10.1038/sj.gt.3302756
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2006 AND VI 13 AND IP 17
Results: 8
1
2
Direct adenovirus-mediated IGF-I gene transduction of synovium induces persisting synovial fluid IGF-I ligand elevations.
- Published in:
- Gene Therapy, 2006, v. 13, n. 17, p. 1253, doi. 10.1038/sj.gt.3302757
- By:
- Publication type:
- Article
3
Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice.
- Published in:
- Gene Therapy, 2006, v. 13, n. 17, p. 1300, doi. 10.1038/sj.gt.3302766
- By:
- Publication type:
- Article
4
Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia.
- Published in:
- Gene Therapy, 2006, v. 13, n. 17, p. 1281, doi. 10.1038/sj.gt.3302774
- By:
- Publication type:
- Article
5
Effect of BMP-2 gene transfer on bone healing in sheep.
- Published in:
- Gene Therapy, 2006, v. 13, n. 17, p. 1290, doi. 10.1038/sj.gt.3302785
- By:
- Publication type:
- Article
6
Modulation of TNFα, a determinant of acute toxicity associated with systemic delivery of first-generation and helper-dependent adenoviral vectors.
- Published in:
- Gene Therapy, 2006, v. 13, n. 17, p. 1272, doi. 10.1038/sj.gt.3302792
- By:
- Publication type:
- Article
7
A guanylate kinase/HSV-1 thymidine kinase fusion protein enhances prodrug-mediated cell killing.
- Published in:
- Gene Therapy, 2006, v. 13, n. 17, p. 1309, doi. 10.1038/sj.gt.3302794
- By:
- Publication type:
- Article
8
Conditional gene expression: Intelligent designs.
- Published in:
- Gene Therapy, 2006, v. 13, n. 17, p. 1251, doi. 10.1038/sj.gt.3302829
- By:
- Publication type:
- Article